Novoeight® is designed with you in mind

Works like natural factor VIII to control bleeds

When activated in the body, Novoeight® works like the factor VIII the body naturally produces. In a clinical trial, Novoeight® was shown to safely and effectively control bleeds in 213 previously treated patients.

Young man, living with hemophilia A walking on the beach


Malcolm, 18 years old,
lives with hemophilia A.


 



 

Offers effective bleed control

Chart illustrating results of Novoeight® clinical study

Of all bleeds during initial clinical trials of Novoeight®, 91% were controlled with 1 or 2 doses.


In initial clinical trials, previously treated patients who took Novoeight® had a median of 3.1 bleeds per year.a


Most people who took part in those initial clinical trials continued to receive Novoeight® to further study safety. These people had a median of 1.7 bleeds per year.a,b


a
Based on median annualized bleeding rate (ABR).
bBased on information as of September 1, 2012.


 



 

Image of Novoeight® medicine being filtered

High standards for purity

Learn about Novo Nordisk's rigorous 5-step purification process.


 

The number 8 in Novoeight®

See how Novoeight® fits into your world

The Novoeight® Brochure highlights all the key features of treatment, so you and your family can learn how Novoeight® may help.


 



 

Selected Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.
 

Indications and Usage

Novoeight® (Antihemophilic Factor [Recombinant]) is an injectable medicine used to control and prevent bleeding in people with hemophilia A. Your healthcare provider may give you Novoeight® when you have surgery.

Novoeight® is not used to treat von Willebrand Disease.
 

Important Safety Information

You should not use Novoeight® if you are allergic to factor VIII or any of the other ingredients of Novoeight® or if you are allergic to hamster proteins.

Call your healthcare provider right away and stop treatment if you get any of the following signs of an allergic reaction: rashes or hives, difficulty breathing or swallowing, tightness of the chest, swelling of the lips and tongue, light-headedness, dizziness or loss of consciousness, pale and cold skin, fast heartbeat, or red or swollen face or hands.

Before taking Novoeight®, you should tell your healthcare provider if you have or have had any medical conditions, take any medicines (including non-prescription medicines and dietary supplements), are nursing, pregnant or planning to become pregnant, or have been told that you have inhibitors to factor VIII.

Your body can make antibodies called “inhibitors” against Novoeight®, which may stop Novoeight® from working properly. Call your healthcare provider right away if your bleeding does not stop after taking Novoeight®.

Common side effects of Novoeight® include swelling or itching at the location of injection, changes in liver tests, and fever.

Please click here for Novoeight® Prescribing Information.

Novoeight® is a prescription medication.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.